Fingerprint
Dive into the research topics where David Burke is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma
Mehta, I., Dayimu, A., Kumar, S., Boobier, C., Oladipo, O., Burke, D., Olson-Brown, A., Yesildag, P., Nobes, J., Brown, S., Booth, C., Wheater, M., Muller, D., Fountain, V., Ford, L., Board, R., McGurk, L., Twelves, S., Demiris, N. & Corrie, P., Nov 2023, In: European Journal of Cancer. 194, 113344.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Citations (Scopus) -
A CRUK first-in-human phase I trial of LY3143921, a novel CDC7 inhibitor, in patients with advanced solid tumors.
Gallagher, P. F., Naylor, G., Bashir, S., Yan, X., Burke, D., Plummer, E. R., Evans, T. R. J., Coyle, V. M., Clive, S., McGuigan, L., Heinzmann, K., Halbert, G., Veal, G., Tiplady, E., Barnett, S., Yalla, K., Brook, S., Dobbs, N. & Wilson, R. H., 01 Jun 2022, In: Journal of Clinical Oncology. 40, 16_suppl, 3103.Research output: Contribution to journal › Meeting abstract › peer-review
Open Access